BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12063019)

  • 1. Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests.
    Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Drandi D; Volpato F; Giaccone L; Giaretta F; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M
    Exp Hematol; 2002 Jun; 30(6):529-36. PubMed ID: 12063019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients.
    Bird JM; Bloxham D; Samson D; Marcus RE; Russell NH; Kelsey SM; Newland AC; Apperley JF
    Br J Haematol; 1994 Sep; 88(1):110-6. PubMed ID: 7803232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting.
    Lopez M; Lemoine FM; Firat H; Fouillard L; Laporte JP; Lesage S; Isnard F; Stachowiak J; Ferrer-Le Coeur F; Morel P; Najman A; Douay L; Gorin NC
    Blood; 1997 Oct; 90(7):2830-8. PubMed ID: 9326252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.
    Vescio RA; Han EJ; Schiller GJ; Lee JC; Wu CH; Cao J; Shin J; Kim A; Lichtenstein AK; Berenson JR
    Bone Marrow Transplant; 1996 Jul; 18(1):103-10. PubMed ID: 8832002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring IgH levels in patients with B-cell malignancy by real-time quantitative PCR after hematopoietic stem cell transplantation and its significance].
    Yu Z; Wang YF; Li ZJ; Zhou Z; Xu SC; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1236-9. PubMed ID: 18088474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour kinetics in multiple myeloma before, during, and after treatment.
    Lincz LF; Crooks RL; Way SL; Granter N; Spencer A
    Leuk Lymphoma; 2001 Jan; 40(3-4):373-84. PubMed ID: 11426560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
    Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K
    Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
    Leung W; Chen AR; Klann RC; Moss TJ; Davis JM; Noga SJ; Cohen KJ; Friedman AD; Small D; Schwartz CL; Borowitz MJ; Wharam MD; Paidas CN; Long CA; Karandish S; McMannis JD; Kastan MB; Civin CI
    Bone Marrow Transplant; 1998 Nov; 22(10):971-9. PubMed ID: 9849694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
    Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
    Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources.
    Léonard BM; Hétu F; Busque L; Gyger M; Bélanger R; Perreault C; Roy DC
    Blood; 1998 Jan; 91(1):331-9. PubMed ID: 9414302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia.
    Owen RG; Johnson RJ; Evans PA; Smith GM; Child JA; Morgan GJ
    Bone Marrow Transplant; 1995 Dec; 16(6):831-4. PubMed ID: 8750277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
    Corradini P; Astolfi M; Cherasco C; Ladetto M; Voena C; Caracciolo D; Pileri A; Tarella C
    Blood; 1997 Jan; 89(2):724-31. PubMed ID: 9002976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.
    Lazarus HM; Haynesworth SE; Gerson SL; Caplan AI
    J Hematother; 1997 Oct; 6(5):447-55. PubMed ID: 9368181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
    Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
    Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
    Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
    Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonality detection in apheresis products from multiple myeloma and non-Hodgkin lymphoma patients.
    Araújo MJ; Carvalhais A; Campos A; Vaz CP; Campilho F; Pimentel P; Barbosa IL
    Transplant Proc; 2000 Dec; 32(8):2676. PubMed ID: 11134758
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
    Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC
    Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
    Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
    Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.